Eagle Pharmaceuticals, Inc. (EGRX)

Last Closing Price: 0.88 (2024-10-11)

Days Sales in Receivables (Annual)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Eagle Pharmaceuticals, Inc. (EGRX) had Days Sales in Receivables of 83.51 for the most recently reported fiscal year, ending 2022-12-31.

Figures for fiscal year ending 2022-12-31
Income Statement Financials
$316.61M
$35.64M
$94.94M
$221.67M
$235.65M
$80.96M
$-19.53M
$61.43M
$61.43M
$35.64M
$35.64M
$35.64M
$35.64M
$80.96M
$94.70M
12.93M
13.06M
$2.76
$2.73
Balance Sheet Financials
$188.75M
$1.17M
$217.41M
$406.16M
$111.09M
$56.22M
$61.51M
$172.60M
$233.56M
$70.20M
$233.56M
13.02M
Cash Flow Statement Financials
$50.70M
$-86.83M
$-6.21M
$97.66M
$55.32M
$-42.34M
$16.45M
--
--
Fundamental Metrics & Ratios
1.70
--
--
0.19
0.27
70.01%
25.57%
25.57%
29.91%
19.40%
11.26%
$50.52M
--
--
--
0.78
1.99
4.37
Days Sales in Receivables
83.51
15.26%
50.77%
8.78%
12.30%
$17.94
$3.87
$3.88